These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 8242244
41. GABAB receptor-mediated inhibition of GABAA receptor calcium elevations in developing hypothalamic neurons. Obrietan K, van den Pol AN. J Neurophysiol; 1998 Mar; 79(3):1360-70. PubMed ID: 9497417 [Abstract] [Full Text] [Related]
42. Opposite effects of GABAB receptor antagonists on absences and convulsive seizures. Vergnes M, Boehrer A, Simler S, Bernasconi R, Marescaux C. Eur J Pharmacol; 1997 Aug 13; 332(3):245-55. PubMed ID: 9300256 [Abstract] [Full Text] [Related]
43. Effect of prolonged 5-hydroxytryptamine uptake inhibition by paroxetine on cortical beta 1 and beta 2-adrenoceptors in rat brain. Nelson DR, Palmer KJ, Johnson AM. Life Sci; 1990 Aug 13; 47(18):1683-91. PubMed ID: 1979137 [Abstract] [Full Text] [Related]
44. Excitatory acoustic responses in the inferior colliculus of the rat are increased by GABAB receptor blockade. Vaughn MD, Pozza MF, Lingenhöhl K. Neuropharmacology; 1996 Aug 13; 35(12):1761-7. PubMed ID: 9076755 [Abstract] [Full Text] [Related]
45. Effect of CGP 36742 on the extracellular level of neurotransmitter amino acids in the thalamus. Nyitrai G, Szárics E, Kovács I, Kékesi KA, Juhász G, Kardos J. Neurochem Int; 1999 May 13; 34(5):391-8. PubMed ID: 10397367 [Abstract] [Full Text] [Related]
46. Presynaptic and postsynaptic GABAB receptors of neocortical neurons of the rat in vitro: differences in pharmacology and ionic mechanisms. Deisz RA, Billard JM, Zieglgänsberger W. Synapse; 1997 Jan 13; 25(1):62-72. PubMed ID: 8987149 [Abstract] [Full Text] [Related]
47. Postnatal ontogeny of GABAB binding in rat brain. Turgeon SM, Albin RL. Neuroscience; 1994 Sep 13; 62(2):601-13. PubMed ID: 7830900 [Abstract] [Full Text] [Related]
48. Positive regulation of GABA(B) receptors dually coupled to cyclic AMP by the allosteric agent CGP7930. Onali P, Mascia FM, Olianas MC. Eur J Pharmacol; 2003 Jun 20; 471(2):77-84. PubMed ID: 12818694 [Abstract] [Full Text] [Related]
49. Examination of the role of inhibition of cyclic AMP in alpha 2-adrenoceptor mediated contractions of the porcine isolated palmar lateral vein. Wright IK, Harling R, Kendall DA, Wilson VG. Br J Pharmacol; 1995 Jan 20; 114(1):157-65. PubMed ID: 7712012 [Abstract] [Full Text] [Related]
50. Chronic (-)baclofen or CGP 36742 alters GABAB receptor sensitivity in rat brain and spinal cord. Malcangio M, Libri V, Teoh H, Constanti A, Bowery NG. Neuroreport; 1995 Jan 26; 6(2):399-403. PubMed ID: 7538812 [Abstract] [Full Text] [Related]
51. Effect of chronic antidepressant treatment on transcription factor binding activity in rat hippocampus and frontal cortex. Frechilla D, Otano A, Del Río J. Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul 26; 22(5):787-802. PubMed ID: 9723120 [Abstract] [Full Text] [Related]
52. Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not beta 2-adrenoceptors in rat cortex. Heal DJ, Butler SA, Hurst EM, Buckett WR. J Neurochem; 1989 Oct 26; 53(4):1019-25. PubMed ID: 2549191 [Abstract] [Full Text] [Related]
53. Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABAB binding sites: a comparison with 5-HT2 binding site changes. Cross JA, Horton RW. Br J Pharmacol; 1988 Feb 26; 93(2):331-6. PubMed ID: 2833970 [Abstract] [Full Text] [Related]
54. Evidence for pharmacologically distinct subsets of GABAB receptors. Scherer RW, Ferkany JW, Enna SJ. Brain Res Bull; 1988 Sep 26; 21(3):439-43. PubMed ID: 2850843 [Abstract] [Full Text] [Related]
55. GABAB receptor-mediated mechanisms in the RVLM studied by microinjections of two GABAB receptor antagonists. Avanzino GL, Ruggeri P, Blanchi D, Cogo CE, Ermirio R, Weaver LC. Am J Physiol; 1994 May 26; 266(5 Pt 2):H1722-8. PubMed ID: 8203572 [Abstract] [Full Text] [Related]
56. Effects of GABAB ligands alone and in combination with paroxetine on hippocampal BDNF gene expression. Khundakar AA, Zetterström TS. Eur J Pharmacol; 2011 Dec 05; 671(1-3):33-8. PubMed ID: 21930121 [Abstract] [Full Text] [Related]
57. Characterization of gamma-aminobutyric acid receptor GABAB(1e), a GABAB(1) splice variant encoding a truncated receptor. Schwarz DA, Barry G, Eliasof SD, Petroski RE, Conlon PJ, Maki RA. J Biol Chem; 2000 Oct 13; 275(41):32174-81. PubMed ID: 10906333 [Abstract] [Full Text] [Related]
58. The serotonin/noradrenaline-link in brain. I. The role of noradrenaline and serotonin in the regulation of density and function of beta adrenoceptors and its alteration by desipramine. Manier DH, Gillespie DD, Sanders-Bush E, Sulser F. Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb 13; 335(2):109-14. PubMed ID: 3031514 [Abstract] [Full Text] [Related]
59. Reduced G-protein coupling to the GABAB receptor in the nucleus accumbens and the medial prefrontal cortex of the rat after chronic treatment with nicotine. Amantea D, Tessari M, Bowery NG. Neurosci Lett; 2004 Jan 30; 355(3):161-4. PubMed ID: 14732456 [Abstract] [Full Text] [Related]
60. CGP 36,742, an orally active GABAB receptor antagonist, facilitates memory in a social recognition test in rats. Mondadori C, Moebius HJ, Zingg M. Behav Brain Res; 1996 May 30; 77(1-2):227-9. PubMed ID: 8762176 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]